6533b81ffe1ef96bd1278f69
RESEARCH PRODUCT
1381P Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC/GEJC) following neoadjuvant chemoradiotherapy (CRT): 14-month follow-up of CheckMate 577
Markus MoehlerGuillermo MendezKaoru KondoAstrid LièvreE. Van CutsemCecile GrootscholtenK. GeboesJames M. ClearyMing LeiJaffer A. AjaniHope E. UronisElena ElimovaS. SoleymaniThomas ZanderSatoru MotoyamaJoshua ZhangGuillaume PiessenJosephine FelicianoJarosław KużdżałRonan J. Kellysubject
Oncologymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentCheckmateCancerHematologymedicine.diseaseGastroesophageal JunctionOncologyInternal medicineMedicineNivolumabbusinessAdjuvantNeoadjuvant chemoradiotherapyMonth follow upyear | journal | country | edition | language |
---|---|---|---|---|
2021-09-01 | Annals of Oncology |